<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ye S</submitter><funding>Young Scientists Fund</funding><funding>Natural Science Foundation of Shanghai</funding><pagination>43</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8996636</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To investigate the alterations of peripheral lymphocyte subpopulations in ovarian cancer patients compared to benign or borderline counterparts. The possible clinicopathological implications were also evaluated.&lt;h4>Methods&lt;/h4>We enrolled 112 treatment-naive ovarian cancer patients, 14 borderline tumor patients and 44 benign tumor patients between 09/2016 and 01/2019. Flow cytometry was used to measure the peripheral lymphocyte subsets consisting of T cells (CD3&lt;sup>+&lt;/sup>, CD3&lt;sup>+&lt;/sup>CD4&lt;sup>+&lt;/sup>, CD3&lt;sup>+&lt;/sup>CD8&lt;sup>+&lt;/sup> and CD8&lt;sup>+&lt;/sup>CD28&lt;sup>+&lt;/sup>), regulatory T cells (Tregs, CD4&lt;sup>+&lt;/sup>CD25&lt;sup>+&lt;/sup>CD127&lt;sup>-&lt;/sup>), natural killer cells (NK cells, CD3&lt;sup>-&lt;/sup>CD56&lt;sup>+&lt;/sup>) and B cells (CD19&lt;sup>+&lt;/sup>).&lt;h4>Results&lt;/h4>Most ovari</pubmed_abstract><journal>Journal of ovarian research</journal><pubmed_title>Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.</pubmed_title><pmcid>PMC8996636</pmcid><funding_grant_id>81702558</funding_grant_id><funding_grant_id>20ZR1413000</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Ye S</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Ping B</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Xiang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.</name><description>&lt;h4>Background&lt;/h4>To investigate the alterations of peripheral lymphocyte subpopulations in ovarian cancer patients compared to benign or borderline counterparts. The possible clinicopathological implications were also evaluated.&lt;h4>Methods&lt;/h4>We enrolled 112 treatment-naive ovarian cancer patients, 14 borderline tumor patients and 44 benign tumor patients between 09/2016 and 01/2019. Flow cytometry was used to measure the peripheral lymphocyte subsets consisting of T cells (CD3&lt;sup>+&lt;/sup>, CD3&lt;sup>+&lt;/sup>CD4&lt;sup>+&lt;/sup>, CD3&lt;sup>+&lt;/sup>CD8&lt;sup>+&lt;/sup> and CD8&lt;sup>+&lt;/sup>CD28&lt;sup>+&lt;/sup>), regulatory T cells (Tregs, CD4&lt;sup>+&lt;/sup>CD25&lt;sup>+&lt;/sup>CD127&lt;sup>-&lt;/sup>), natural killer cells (NK cells, CD3&lt;sup>-&lt;/sup>CD56&lt;sup>+&lt;/sup>) and B cells (CD19&lt;sup>+&lt;/sup>).&lt;h4>Results&lt;/h4>Most ovari</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T12:40:20.543Z</modification><creation>2025-04-04T12:40:20.543Z</creation></dates><accession>S-EPMC8996636</accession><cross_references><pubmed>35410290</pubmed><doi>10.1186/s13048-022-00977-3</doi></cross_references></HashMap>